Skip to main content
SK Biopharmaceuticals Co., Ltd. (KRX:326030)
South Korea flag South Korea · Delayed Price · Currency is KRW
90,400
-7,500 (-7.66%)
At close: May 9, 2025, 3:30 PM KST

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
New Drugs
547.60B
Log In
Log In
Log In
Log In
New Drugs Growth
54.30%
Log In
Log In
Log In
Log In
Service
-
Log In
Log In
Log In
Log In
Service Growth
-
Log In
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Consolidated Adjustment
-594.66B
Log In
Log In
Log In
Log In
Consolidated Adjustment Growth
27.97%
Log In
Log In
Log In
Log In
United States
667.82B
Log In
Log In
Log In
Log In
United States Growth
31.23%
Log In
Log In
Log In
Log In
South Korea
474.43B
Log In
Log In
Log In
Log In
South Korea Growth
52.69%
Log In
Log In
Log In
Log In
Consolidated Adjustment
-594.66B
Log In
Log In
Log In
Log In
Consolidated Adjustment Growth
27.97%
Log In
Log In
Log In
Log In
Cayman Islands
-
Log In
Log In
Log In
Log In
Netherlands
-
Log In
Log In
Log In
Log In
Canada
-
Log In
Log In
Log In
Log In
Japan
-
Log In
Log In
Log In
Log In
Ireland
-
Log In
Log In
Log In
Log In